# Some really interesting news from Sanofi recently, in the hot AI in clinical trials space: Format...

> Formation Bio, in collaboration with Sanofi and OpenAI, has introduced Muse, an AI-powered tool designed to optimize patient recruitment in clinical trials. I think it will be fascinating to watch how this three-party collaboration — Big Pharma, Health Tech, and Large Tech — evolves, and I wouldn't be surprised to see more of these partnerships emerge in the coming year.

URL: https://www.ch-healthtech.com/insights/some-really-interesting-news-sanofi-recently-hot-ai-clinical-trials-space-format
Markdown: https://www.ch-healthtech.com/insights/some-really-interesting-news-sanofi-recently-hot-ai-clinical-trials-space-format.md
Published: 2024-11-18
Updated: 2026-05-06
Author: Christian Hein
Tags: technology/artificial-intelligence, technology/agentic-ai, technology/in-silico-clinical-trials, industry/large-pharma, industry/health-tech, activity/partnership-alliance, function/clinical-development

---


Some really interesting news from Sanofi recently, in the hot AI in clinical trials space: Formation Bio, in collaboration with Sanofi and OpenAI, has introduced Muse, an AI-powered tool designed to optimize patient recruitment in clinical trials. Some interesting elements in there, like a dedicated LLM agent that incorporates Institutional Review Board and regulatory guidelines, and auto-generation of recruitment materials and pre-screening questionnaires.

In the bigger picture, it will be fascinating to watch how this three-party collaboration - Big Pharma, Health Tech, and Large Tech - evolves over time. Given the momentum in the sector, I wouldn't be surprised to see more of these partnerships emerge in the coming year as AI continues to reshape clinical operations and healthcare at large.

https://lnkd.in/edGi267i